Source: Eur Respir J 2007; 30: 1131-1137
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Bathoorn E., Slebos D-J., Postma D. S., Koeter G. H., van Oosterhout A. J. M., van der Toorn M., Boezen H. M., Kerstjens H. A. M.. Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J 2007; 30: 1131-1137

Member's Comments

No comment yet.

Related content which might interest you: No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib Source: International Congress 2016 – IPF treatment II Year: 2016 Comparative study of hospitalized patients with acute exacerbation of COPD with and without carbon dioxide retention Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Effects of low dose inhaled carbon monoxide in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 661s Year: 2006 Effects of hydrogen sulfide on ozone-induced features of chronic obstructive pulmonary disease Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 The importance of measuriing exhaled carbon monoxide in asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 82s Year: 2003 The diagnostic value of exhaled carbon monoxide and arterial carboxyhaemoglobin measurements in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006 Exhaled carbon monoxide measurement in patients with interstitial lung diseases (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis Source: Eur Respir J 2002; 20: 92-99 Year: 2002 Nitric oxide and oxygen inhalation during exercise in patients with chronic obstructive lung disease (COPD) and secondary pulmonary hypertension (PH) Source: Eur Respir J 2001; 18: Suppl. 33, 83s Year: 2001 Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006 Exhaled carbon monoxide correlates with airway neutrophilia in patients with chronic allograft dysfunction (BOS) after lung transplantation Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Increased levels of exhaled carbon monoxide and their correlation with airflow obstruction in asthma and COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012 Relationship between diffusing capacity for carbon monoxide and severity of airway obstruction, presence of cor pulmonale chronic in obese and nonobese stable COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 726s Year: 2006 Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease Source: International Congress 2016 – Smoking-related diseases Year: 2016 Effects of long-acting inhaled β-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with COPD Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006 Can we use the evaluation of leukotriens in breath condensate for the diagnosis of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004 Exhaled carbon monoxide is decreased in interstitial lung diseases (ILD) Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001 Monitoring exhaled carbon monoxide in COPD exacerbations Source: International Congress 2014 – Airway biomarkers Year: 2014 Diffusing capacity for carbon monoxide and mortality in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 The influence of statin supplementation on inflammatory markers in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015